Home/Pipeline/ChondroStem™ Allogeneic

ChondroStem™ Allogeneic

Lumbar Degenerative Disc Disease

Phase 2/3Active

Key Facts

Indication
Lumbar Degenerative Disc Disease
Phase
Phase 2/3
Status
Active
Company

About Cell Technologies

Regenerative stem‑cell therapies for OA and spinal disease, with FDA/Health Canada approval.

View full company profile